R Zacest, E Gilmore, J Koch-Weser. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Administration, OralAdrenergic beta-Antagonists/administration & dosageAdrenergic beta-Antagonists/pharmacologyAdrenergic beta-Antagonists/therapeutic useAdultAgedBlood Pressure/drug effectsDiuretics/administration & dosageFemaleGuanethidine/therapeutic useHeart Rate/drug effectsHumansHydralazine/administration & dosageHydralazine/pharmacologyHypertension/drug therapyHypertension/physiopathologyInjections, IntravenousMaleMethyldopa/therapeutic useMiddle AgedPosturePropranolol/administration & dosagePropranolol/pharmacologyPropranolol/therapeutic useVasodilator Agents/administration & dosage
Substances: See more » Adrenergic beta-AntagonistsDiureticsVasodilator AgentsHydralazineMethyldopaPropranololGuanethidine
Year: 1972 PMID: 4401216 DOI: 10.1056/NEJM197203232861201
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245